Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Using CAR-T cell techniques to treat myelofibrosis
Read more on how Dr Pule is using CAR-T cell techniques provide an alternative and potentially less harmful treatment for young people affected by myelofibrosis.
Advancing treatment for leukaemia
Professor Milne wants to find out why drugs that block a protein called menin only work for some people to help make drugs effective for more people with leukaemia.
Understanding how MALT lymphoma develops
In this research project, Professor Du will investigate how MALT lymphoma develops to try and find new ways to treat it.
Understanding how MPN develops
In this project, Professor Hitchcock wants to understand more about how MPN develops.
Finding out how our genetic code might cause myeloproliferative neoplasms (MPN)
By studying the DNA of people with myeloproliferative neoplasms (MPN), Professor Anderson aims to uncover what causes the disease.
Finding new ways to treat chronic myeloid leukaemia (CML)
Dr Oberoi wants to understand more about a specific protein to see if she can find ways to switch it off to stop the growth of CML cancer cells.
Developing more effective treatments for people with blood cancer
By uncovering how a key molecule behaves in blood cancer cells, researchers aim to improve treatments when current therapies stop working.
Finding new and better ways to treat leukaemia in babies
Some childhood leukaemias are caused by changes in a specific gene and are hard to treat, often returning after treatment. Dr Tom Milne’s research aims to develop new ways to treat leukaemia in babies.
Making CAR-T cell therapy more effective for people with T-cell acute lymphoblastic leukaemia (T-ALL)
Dr Paul Maciocia is working to make CAR-T cell therapy a more effective treatment for people with T-ALL
Understanding how some cancer cells are shielded from chemotherapy
Dr Ingo Ringhausen wants to understand more about how CLL cells can resist treatment.
Finding new ways to treat AML
Professor Tonks is studying what drives AML to try and find new treatment targets for people with the disease.
Understanding how Adult T-cell lymphoma develops
In this research project, Dr Maertens wants to understand how a virus can cause a rare type of lymphoma.
Understanding how fat cells are involved in myeloma returning
In this research project, Professor Claire Edwards will look at how fat cells are involved in myeloma progressing.
Understanding how childhood B-ALL develops
Professor Enver wants to find out more about how childhood B-ALL develops so he can prevent it from happening or find better ways to treat it.
Finding new ways to treat MPN
In this blood cancer research project, Dr Mishto wants to understand whether we might be able to harness our immune system to treat Myeloproliferative neoplasm (MPN).
Understanding whether we can prevent acute myeloid leukaemia
Find out more about Professor George Vassiliou's study into preventing people from developing acute myeloid leukaemia (AML), by seeing if DNMT3A is responsible for cells becoming ‘pre-leukaemic'.
Studying how the immune system behaves in myeloma
tba
The STELLAR trial: Finding new treatments for Richter’s syndrome
Richter’s syndrome is a complication of chronic lymphocytic leukaemia. Blood Cancer UK researchers will add a drug to treatment to see if this improves outcome.
EuroNet-PHL-C2 trial
Researchers are exploring whether tailored chemotherapy can reduce the need for radiotherapy in children and young people.
UKALL 2011
Discover Professor Pamela Kearns's UKALL 2011 trial that looks at treatment for children who have acute lymphoblastic leukaemia (ALL) or a type of non-Hodgkin lymphoma (NHL) called lymphoblastic lymphoma (LBL).
Repurposing drugs to treat acute myeloid leukaemia
Researchers are looking at whether existing drugs for solid tumours can treat AML. This could provide a new option for people with the disease.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.